FDA. 2007 (July). Emergency Use Authorization of medical products: Guidance, http://www.fda.gov/RegulatoryInformation/Guidances/ucm125127.htm#publication (accessed July 5, 2010).

FDA. 2008 (February 5). Letter of Emergency Use Authorization for the preevent provision and potential use of doxycycline hyclate tablet emergency kits for inhalational anthrax, http://www.fda.gov/downloads/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/UCM107309.pdf (accessed August 5, 2010).

FDA. 2010a. Authorizations of emergency use of certain antiviral drugs–zanamivir and oseltamivir phosphate. Federal Register 74(148):38648–38654.

FDA. 2010b. Authorization of emergency use of the antiviral product peramivir accompanied by emergency use information. Federal Register 74(210):56644–56649.

FDA. 2010c. Authorization of emergency use of certain personal respiratory protection devices. Federal Register 74(148):38644–38648.

FDA. 2010d. Medical devices and flu emergencies: Historical information, http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm (accessed August 25, 2010).

HHS (U.S. Department of Health and Human Services). 2010a. Project BioShield, https://www.medicalcountermeasures.gov/BARDA/bioshield/bioshield.aspx (accessed August 2, 2010).

HHS. 2010b. Public Readiness and Emergency Preparedness Act, http://www.phe.gov/preparedness/legal/prepact/Pages/default.aspx (accessed August 2, 2010).

HRSA (Health Resources and Services Administration). 2010a (May 12). Public Readiness and Emergency Preparedness Act Countermeasures Injury Compensation Program, procedures for submitting a letter of intent to file requests for benefits. Federal Register 75(91):26773–26774.

HRSA. 2010b. Countermeasures Injury Compensation Program, http://www.hrsa.gov/gethealthcare/conditions/countermeasurescomp/index.html (accessed August 25, 2010).

IOM (Institute of Medicine). 2008. Dispensing medical countermeasures for public health emergencies: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2010a. The Public Health Emergency Medical Countermeasures Enterprise: Innovative strategies to enhance products from discovery through approval: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2010b. The 2009 H1N1 influenza vaccination campaign: Summary of a workshop series. Washington, DC: The National Academies Press.

NABP (National Association of Boards of Pharmacy). 2010 (August). Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy, http://www.nabp.net/publications/assets/ModelAct.doc (accessed October 29, 2010).

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement